{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:53:51Z","timestamp":1767135231287,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd010081","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,10,7]],"date-time":"2015-10-07T00:00:00Z","timestamp":1444176000000}}],"reference-count":90,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010081.pub2","type":"journal-article","created":{"date-parts":[[2015,10,7]],"date-time":"2015-10-07T07:45:06Z","timestamp":1444203906000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Interventions for hidradenitis suppurativa"],"prefix":"10.1002","volume":"2017","author":[{"given":"John R","family":"Ingram","sequence":"first","affiliation":[{"name":"Cardiff University; Department of Dermatology & Wound Healing, Cardiff Institute of Infection & Immunity; 3rd Floor Glamorgan House Heath Park Cardiff UK CF14 4XN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pick-Ngor","family":"Woo","sequence":"additional","affiliation":[{"name":"Northampton General Hospital NHS Trust; Department of Dermatology; 121 Billing Road Northampton UK NN1 5RR"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ser Ling","family":"Chua","sequence":"additional","affiliation":[{"name":"University Hospitals Birmingham NHS Foundation Trust; Department of Dermatology; Mindelsohn Way Birmingham UK B15 2WB"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony D","family":"Ormerod","sequence":"additional","affiliation":[{"name":"University of Aberdeen; Department of Dermatology, School of Medicine and Dentistry; Ward 29 Aberdeen Royal Infirmary Aberdeen Scotland UK AB25 2ZN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nemesha","family":"Desai","sequence":"additional","affiliation":[{"name":"Guy's and St Thomas' NHS Foundation Trust; St John's Institute of Dermatology; Westminster Bridge Road London UK SE1 7EH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anneke C","family":"Kai","sequence":"additional","affiliation":[{"name":"Guy's and St Thomas' NHS Foundation Trust; St John's Institute of Dermatology; Westminster Bridge Road London UK SE1 7EH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerry","family":"Hood","sequence":"additional","affiliation":[{"name":"Cardiff University; South East Wales Trials Unit, Institute of Translation, Innovation, Methodology and Engagement; 2nd Floor, Neuadd Meirionnydd Heath Park Cardiff Wales UK CF14 4YS"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"Burton","sequence":"additional","affiliation":[{"name":"The Hidradenitis Suppurativa (HS) Trust; P O Box 550 Chatham UK ME4 9AH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Kerdel","sequence":"additional","affiliation":[{"name":"Larkin Community Hospital; Florida Academic Dermatology Center; 1400 nw 12 ave Suite 4 South Miami Florida USA Fl 33136"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E","family":"Garner","sequence":"additional","affiliation":[{"name":"National Institute for Health and Care Excellence (NICE); Science Policy and Research; MidCity Place 71 High Holborn London UK WC1V 6NA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Piguet","sequence":"additional","affiliation":[{"name":"Cardiff University; Department of Dermatology & Wound Healing, Cardiff Institute of Infection & Immunity; 3rd Floor Glamorgan House Heath Park Cardiff UK CF14 4XN"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,10,7]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD010081.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archdermatol.2010.72","article-title":"Treatment of hidradenitis suppurativa with etanercept injection","volume":"146","author":"Adams","year":"2010","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD010081.pub2-BIB0002|cit2","first-page":"111","article-title":"Beneficial effects of staphage lysate in the treatment of chronic recurrent hidradenitis suppurativa","volume":"38","author":"Angel","year":"1987","journal-title":"Surgical Forum"},{"issue":"2","key":"10.1002\/14651858.CD010081.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/00042728-200802000-00012","article-title":"Surgical treatment of hidradenitis suppurativa with gentamicin sulfate: a prospective randomized study","volume":"34","author":"Buimer","year":"2008","journal-title":"Dermatologic Surgery"},{"issue":"5","key":"10.1002\/14651858.CD010081.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-4362.1983.tb02150.x","article-title":"Topical treatment of hidradenitis suppurativa with clindamycin","volume":"22","author":"Clemmensen","year":"1983","journal-title":"International Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD010081.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/ced.12459","article-title":"New topical photodynamic therapy for treatment of hidradenitis suppurativa using methylene blue niosomal gel: a single-blind,randomized, comparative study","volume":"40","author":"Fadel","year":"2015","journal-title":"Clinical & Experimental Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD010081.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2009.06.050","article-title":"Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial","volume":"62","author":"Grant","year":"2010","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD010081.pub2-BIB0007|cit7","first-page":"AB106","article-title":"Long-term efficacy and safety results (60 weeks) of a double-blind, placebo-controlled, crossover trial of infliximab for patients with moderate to severe hidradenitis suppurativa. 67th Annual Meeting of the American Academy of Dermatology. AAD San Francisco, CA United States. Conference Start: 20090306 Conference End: 20090310","volume":"60","author":"Grant","year":"2009","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD010081.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/PRS.0b013e31821e6fb5","article-title":"Treatment of hidradenitis suppurativa with intense pulsed light: a prospective study","volume":"128","author":"Highton","year":"2011","journal-title":"Plastic & Reconstructive Surgery"},{"key":"10.1002\/14651858.CD010081.pub2-BIB0009|cit9","first-page":"101","article-title":"Treatment of hidradenitis suppurativa using intense pulsed light. 29th Annual Conference of the American Society for Laser Medicine and Surgery National Harbor, MD United States. Conference Start: 20090401 Conference End: 20090405","volume":"41","author":"Highton","year":"2009","journal-title":"Lasers in Surgery and Medicine"},{"issue":"6","key":"10.1002\/14651858.CD010081.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0190-9622(98)70272-5","article-title":"Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa","volume":"39","author":"Jemec","year":"1998","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD010081.pub2-BIB0011|cit11","first-page":"220A","article-title":"Adalimumab treatment in women with moderate to severe hidradenitis suppurativa using a novel endpoint, HISCR (hidradenitis suppurativa clinical response): Analysis from the placebo-controlled portion of a phase ii, randomized, double-blind study. 61st Annual Scientific Meeting of the Society for Gynecologic Investigation, SGI 2014 Florence Italy. Conference Start: 20140326 Conference End: 20140329","volume":"21","author":"Gottlieb","year":"2014","journal-title":"Reproductive Sciences"},{"key":"10.1002\/14651858.CD010081.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"S360","DOI":"10.1016\/S0020-7292(12)60712-7","article-title":"Efficacy and safety of adalimumab treatment in women with moderate to severe hidradenitis suppurativa: Analysis from the placebo-controlled portion of a phase ii, randomized, double-blind study. 20th FIGO World Congress of Gynecology and Obstetrics Rome Italy. Conference Start: 20121007 Conference End: 20121012","volume":"119","author":"Gottlieb","year":"2012","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD010081.pub2-BIB0013|cit13","first-page":"AB42","article-title":"Efficacy results using a novel hidradenitis suppurativa endpoint, HiSCR (hidradenitis suppurativa clinical response), from the placebo-controlled phase of a phase 2 adalimumab study. Conference: 72nd Annual Meeting of the American Academy of Dermatology Denver, CO United States. Conference Start: 20140321 Conference End: 20140325","volume":"70","author":"Jemec","year":"2014","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD010081.pub2-BIB0014|cit14","first-page":"AB155","article-title":"Efficacy and safety of adalimumab in treatment of moderate to severe hidradenitis suppurativa: results from the placebo-controlled portion of a phase ii, randomized, double-blind study. Conference: 69th Annual Meeting of the American Academy of Dermatology New Orleans, LA United States. Conference Start: 20110204 Conference End: 20110208","volume":"64","author":"Kimball","year":"2011","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD010081.pub2-BIB0015|cit15","first-page":"AB50","article-title":"Efficacy and safety of adalimumab for moderate to severe hidradenitis suppurativa: Results from the open-label phase of a 52-week phase II, randomized, study. 70th Annual Meeting of the American Academy of Dermatology San Diego, CA United States. Conference Start: 20120316 Conference End: 20120320","volume":"66","author":"Kimball","year":"2012","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4 Suppl 1","key":"10.1002\/14651858.CD010081.pub2-BIB0016|cit16","first-page":"AB42","article-title":"Adalimumab reduces pain in patients with hidradenitis suppurativa: Results from a placebo-controlled phase II trial. 70th Annual Meeting of the American Academy of Dermatology San Diego, CA United States. Conference Start: 20120316 Conference End: 20120320","volume":"66","author":"Kimball","year":"2012","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010081.pub2-BIB0017|cit17","first-page":"6","article-title":"Efficacy and safety of adalimumab in the treatment of moderate to severe hidradenitis suppurativa: results from the placebo-controlled portion of phase II, randomized, double-blind study. 91st Annual Meeting of the British Association of Dermatologists London United Kingdom. Conference Start: 20110705 Conference End: 20110707","volume":"165","author":"Kimball","year":"2011","journal-title":"British Journal of Dermatology"},{"issue":"12","key":"10.1002\/14651858.CD010081.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"846","DOI":"10.7326\/0003-4819-157-12-201212180-00004","article-title":"Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial","volume":"157","author":"Kimball","year":"2012","journal-title":"Annals of Internal Medicine"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD010081.pub2-BIB0019|cit19","first-page":"AB35","article-title":"Adalimumab treatment is associated with pain reduction in patients with hidradenitis suppurativa, regardless of the presence of depression: Results from a phase II, randomized, placebo-controlled trial. 72nd Annual Meeting of the American Academy of Dermatology Denver, CO United States. Conference Start: 20140321 Conference End: 20140325","volume":"70","author":"Scheinfeld","year":"2014","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD010081.pub2-BIB0020|cit20","first-page":"S67","article-title":"High-sensitivity C-reactive protein response to adalimumab in hidradenitis suppurativa patients. 42nd Annual Meeting of the European Society for Dermatological Research Venice Italy. Conference Start: 20120919 Conference End: 20120922","volume":"132","author":"Zouboulis","year":"2012","journal-title":"Journal of Investigative Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD010081.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2133.2011.10339.x","article-title":"A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa","volume":"165","author":"Miller","year":"2011","journal-title":"British Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD010081.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2133.1986.tb05740.x","article-title":"A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa","volume":"115","author":"Mortimer","year":"1986","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD010081.pub2-BIB0023|cit23","first-page":"100","article-title":"Prospective clinical and histopathologic study of hidradenitis suppurativa treated with laser. 29th Annual Conference of the American Society for Laser Medicine and Surgery National Harbor, MD United States. Conference Start: 20090401 Conference End: 20090405","volume":"41","author":"Hamzavi","year":"2009","journal-title":"Lasers in Surgery and Medicine"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD010081.pub2-BIB0024|cit24","first-page":"AB192","article-title":"Clinical and histopathologic evaluation of hidradenitis suppurativa treated with long-pulsed Nd:YAG laser. 67th Annual Meeting of the American Academy of Dermatology, AAD San Francisco, CA United States. Conference Start: 20090306 Conference End: 20090310","volume":"60","author":"Mahmoud","year":"2009","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD010081.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jaad.2009.07.048","article-title":"Prospective controlled clinical and histopathologic study of hidradenitis suppurativa treated with the long-pulsed neodymium:yttrium-aluminium-garnet laser","volume":"62","author":"Mahmoud","year":"2010","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"8","key":"10.1002\/14651858.CD010081.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1524-4725.2009.01214.x","article-title":"Randomized control trial for the treatment of hidradenitis suppurativa with a neodymium-doped yttrium aluminium garnet laser","volume":"35","author":"Tierney","year":"2009","journal-title":"Dermatologic Surgery"},{"issue":"4","key":"10.1002\/14651858.CD010081.pub2-BIB0027|cit27","first-page":"235","article-title":"A comparison of skin grafting and healing by granulation, following axillary excision for hidradenitis suppurativa","volume":"65","author":"Morgan","year":"1983","journal-title":"Annals of the Royal College of Surgeons of England"},{"key":"10.1002\/14651858.CD010081.pub2-BIB0028|cit28","unstructured":"NCT00722800 A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS clinicaltrials.gov\/ct2\/show\/NCT00722800"},{"issue":"6","key":"10.1002\/14651858.CD010081.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"650","DOI":"10.4103\/0019-5154.91821","article-title":"A study on the management of hidradenitis suppurativa with retinoids and surgical excision","volume":"56","author":"Puri","year":"2011","journal-title":"Indian Journal of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD010081.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1054\/bjps.1999.3285","article-title":"Chronic axillary hidradenitis--the efficacy of wide excision and flap coverage","volume":"53","author":"Soldin","year":"2000","journal-title":"British Journal of Plastic Surgery"},{"issue":"1","key":"10.1002\/14651858.CD010081.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/archdermatol.2010.245","article-title":"Histopathologic study of hidradenitis suppurativa following long-pulsed 1064-nm Nd:YAG laser treatment","volume":"147","author":"Xu","year":"2011","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD010081.pub2-BIB0032|cit32","unstructured":"EUCTR2006-005405-67 Study of the effectiveness and tolerance of L35 versus placebo in the treatment of hidradenitis suppurativa (Verneuil 's Disease) www.clinicaltrialsregister.eu\/ctr-search\/search?query=2006-005405-67"},{"key":"10.1002\/14651858.CD010081.pub2-BIB0033|cit33","unstructured":"EUCTR2007-000534-39 Comparative randomised study on the effectiveness of the treatment of hidradenitis suppurative disease or verneuil by sub cutaneous injections of botulinum toxin versus placebo www.clinicaltrialsregister.eu\/ctr-search\/trial\/2007-000534-39\/FR"},{"key":"10.1002\/14651858.CD010081.pub2-BIB0034|cit34","unstructured":"Servant JM Couturaud B Briand E Algosteril range (calcium alginate rope\/dressing\/powder) versus tulle gras lumiere\/vaseline (vaseline gauze) in the treatment of lesions due to Verneuil's disease 4th Australian Wound Management Association Conference, Adelaide, South Australia Adelaide 2002"},{"key":"10.1002\/14651858.CD010081.pub2-BIB0035|cit35","unstructured":"NCT01063270 Trial Comparing Efficacy of Treatments for Hidradenitis Suppurativa clinicaltrials.gov\/show\/NCT01063270"},{"key":"10.1002\/14651858.CD010081.pub2-BIB0036|cit36","first-page":"S31","article-title":"Adalimumab improves treatment satisfaction with medication (TS-M) in patients with moderate to severe Hidradenitis Suppurativa (HS) in a 12-week randomised controlled trial (PIONEER I). 44th Annual Meeting of the European Society for Dermatological Research Copenhagen Denmark. Conference Start: 20140910 Conference End: 20140913","volume":"134","author":"Jemec","year":"2014","journal-title":"Journal of Investigative Dermatology"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD010081.pub2-BIB0037|cit37","first-page":"AB60","article-title":"Safety and efficacy of adalimumab in patients with moderate to severe hidradenitis suppurativa: Results from first 12 weeks of PIONEER I, a phase 3, randomized, placebo-controlled trial. 73rd Annual Meeting of the American Academy of Dermatology San Francisco, CA United States","volume":"72","author":"Kimball","year":"2015","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD010081.pub2-BIB0038|cit38","first-page":"S36","article-title":"Safety and efficacy of adalimumab in patients with moderate to severe hidradenitis suppurativa: results from first 12 weeks of PIONEER I, a phase 3, randomized, placebo-controlled trial. 44th Annual Meeting of the European Society for Dermatological Research Copenhagen Denmark. Conference Start: 20140910 Conference End: 20140913","volume":"134","author":"Kimball","year":"2014","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1002\/14651858.CD010081.pub2-BIB0039|cit39","unstructured":"NCT01468207 Efficacy and Safety Study of Adalimumab in Treatment of Hidradenitis Suppurativa (PIONEER I) clinicaltrials.gov\/show\/NCT01468207"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD010081.pub2-BIB0040|cit40","first-page":"AB38","article-title":"Adalimumab improves health-related quality of life (HRQoL) in patients with moderate to severe hidradenitis suppurativa (HS): results from the first 12 weeks of PIONEER II. 73rd Annual Meeting of the American Academy of Dermatology San Francisco, CA United States. Conference Start: 20150320 Conference End: 20150324","volume":"72","author":"Armstrong","year":"2015","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD010081.pub2-BIB0041|cit41","first-page":"AB45","article-title":"Efficacy and safety of adalimumab in patients with moderate to severe hidradenitis suppurativa: Results from PIONEER II, a phase 3, randomized, placebo-controlled trial. 73rd Annual Meeting of the American Academy of Dermatology San Francisco, CA United States. Conference Start: 20150320 Conference End: 20150324","volume":"72","author":"Jemec","year":"2015","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD010081.pub2-BIB0042|cit42","first-page":"AB39","article-title":"Adalimumab improves treatment satisfaction with medication (TS-M) in patients with moderate to severe hidradenitis suppurativa (HS) in a 12-week randomized controlled trial (PIONEER II)","volume":"72","author":"Jemec","year":"2015","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD010081.pub2-BIB0043|cit43","first-page":"AB39","article-title":"Adalimumab is associated with reduced skin pain in patients with moderate to severe hidradenitis suppurativa (HS): Results from the first 12 weeks of PIONEER II. 73rd Annual Meeting of the American Academy of Dermatology San Francisco, CA United States","volume":"72","author":"Kimball","year":"2015","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD010081.pub2-BIB0044|cit44","unstructured":"NCT01468233 Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa (PIONEER II) clinicaltrials.gov\/show\/NCT01468233"},{"key":"10.1002\/14651858.CD010081.pub2-BIB0045|cit45","unstructured":"NCT01558375 Anakinra in Hidradenitis Suppurativa clinicaltrials.gov\/show\/NCT01558375"},{"key":"10.1002\/14651858.CD010081.pub2-BIB0046|cit46","unstructured":"NCT01818167 An Investigation Into the Efficacy of Provodine Topical Cream as Compared to 10% Benzoyl Peroxide Wash for the Treatment of Hidradenitis Suppurativa clinicaltrials.gov\/ct2\/show\/NCT01818167"},{"key":"10.1002\/14651858.CD010081.pub2-BIB0047|cit47","unstructured":"NCT01838499 Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa clinicaltrials.gov\/ct2\/show\/NCT01838499"},{"key":"10.1002\/14651858.CD010081.pub2-BIB0048|cit48","unstructured":"NCT02163746 Study to Compare Two Treatments for Axillary Hidradenitis Suppurativa: Carbon Dioxide Laser Versus Surgical Deroofing clinicaltrials.gov\/ct2\/show\/NCT02163746"},{"key":"10.1002\/14651858.CD010081.pub2-BIB0049|cit49","unstructured":"NCT02421172 Efficacy, Safety, and Pharmacokinetics Study of CJM112 in Hidradenitis Suppurativa Patients clinicaltrials.gov\/ct2\/show\/NCT02421172"},{"issue":"5","key":"10.1002\/14651858.CD010081.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2165\/11631880-000000000-00000","article-title":"Pharmacologic interventions for hidradenitis suppurativa: what does the evidence say?","volume":"13","author":"Alhusayen","year":"2012","journal-title":"American Journal of Clinical Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD010081.pub2-BIB0051|cit51","first-page":"997","article-title":"The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results","volume":"159","author":"Basra","year":"2008","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD010081.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000365390","article-title":"Determining the minimal clinically important difference and responsiveness of the Dermatology Life Quality Index (DLQI): further data","volume":"230","author":"Basra","year":"2015","journal-title":"Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD010081.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/bjd.12104","article-title":"Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review","volume":"168","author":"Blok","year":"2013","journal-title":"British Journal of Dermatology"},{"issue":"7109","key":"10.1002\/14651858.CD010081.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD010081.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clinical & Experimental Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD010081.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1365-2133.2005.06502.x","article-title":"Current severe psoriasis and the Rule of Tens","volume":"152","author":"Finlay","year":"2005","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD010081.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.1985.tb02037.x","article-title":"Evidence of genetic factors in hidradenitis suppurativa","volume":"113","author":"Fitzsimmons","year":"1985","journal-title":"British Journal of Dermatology"},{"issue":"6570","key":"10.1002\/14651858.CD010081.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/bmj.294.6570.487","article-title":"Recurrence after surgical treatment of hidradenitis suppurativa","volume":"294","author":"Harrison","year":"1987","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD010081.pub2-BIB0059|cit59","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"11","key":"10.1002\/14651858.CD010081.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/archdermatol.2010.328","article-title":"Hidradenitis suppurativa and concomitant pyoderma gangrenosum: a case series and literature review","volume":"146","author":"Hsiao","year":"2010","journal-title":"Archives of Dermatology"},{"key":"10.1002\/14651858.CD010081.pub2-BIB0061|cit61","first-page":"729","article-title":"Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach","volume-title":"Dermatologic Surgery","author":"Hurley","year":"1989"},{"issue":"9","key":"10.1002\/14651858.CD010081.pub2-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010081","article-title":"Interventions for hidradenitis suppurativa","author":"Ingram","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010081.pub2-BIB0063|cit63","doi-asserted-by":"crossref","unstructured":"Ingram JR Abbott R Ghazavi M Alexandroff AB McPhee M Burton T The Hidradenitis Suppurativa Priority Setting Partnership British Journal of Dermatology 2014 1422 7 10.1111\/bjd.13163","DOI":"10.1111\/bjd.13163"},{"issue":"2","key":"10.1002\/14651858.CD010081.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1001\/jama.294.2.218","article-title":"Contradicted and initially stronger effects in highly cited clinical research","volume":"294","author":"Ioannidis","year":"2005","journal-title":"Journal of the American Medical Association"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD010081.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0190-9622(96)90321-7","article-title":"The prevalence of hidradenitis suppurativa and its potential precursor lesions","volume":"35","author":"Jemec","year":"1996","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD010081.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMcp1014163","article-title":"Clinical practice. Hidradenitis suppurativa","volume":"366","author":"Jemec","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD010081.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2310\/7750.2007.00019","article-title":"Hidradenitis suppurativa in 64 female patients: retrospective study comparing oral antibiotics and antiandrogen therapy","volume":"11","author":"Kraft","year":"2007","journal-title":"Journal of Cutaneous Medicine & Surgery"},{"issue":"4","key":"10.1002\/14651858.CD010081.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/bjd.13090","article-title":"Risk factors, clinical course and long-term prognosis in hidradenitis suppurativa: a cross-sectional study","volume":"171","author":"Kromann","year":"2014","journal-title":"British Journal of Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD010081.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jaad.2011.10.024","article-title":"Profound disturbances of sexual health in patients with acne inversa","volume":"67","author":"Kurek","year":"2012","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD010081.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1365-2133.2008.08932.x","article-title":"Outcomes of treatment of nine cases of recalcitrant severe hidradenitis suppurativa with carbon dioxide laser","volume":"159","author":"Madan","year":"2008","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD010081.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jaad.2009.07.048","article-title":"Prospective controlled clinical and histopathologic study of hidradenitis suppurativa treated with the long-pulsed neodymium:yttrium-aluminium-garnet laser","volume":"62","author":"Mahmoud","year":"2010","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1002\/14651858.CD010081.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/978-3-540-33101-8_8","article-title":"Epidemiology","volume-title":"Hidradenitis Suppurativa","author":"Naldi","year":"2006"},{"issue":"10","key":"10.1002\/14651858.CD010081.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0895-4356(89)90168-6","article-title":"Meta-analysis in medical research: strong encouragement for higher quality in individual research efforts","volume":"42","author":"O'Rourke","year":"1989","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7","key":"10.1002\/14651858.CD010081.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1038\/jid.2011.42","article-title":"PSENEN and NCSTN mutations in familial hidradenitis suppurativa (acne inversa)","volume":"131","author":"Pink","year":"2011","journal-title":"Journal of Investigative Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD010081.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/archdermatol.2011.1950","article-title":"A Systematic Review of Treatments for Hidradenitis Suppurativa","volume":"148","author":"Rambhatla","year":"2012","journal-title":"Archives of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD010081.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","article-title":"Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies","volume":"59","author":"Revuz","year":"2008","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"9","key":"10.1002\/14651858.CD010081.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1468-3083.2009.03356.x","article-title":"Hidradenitis suppurativa","volume":"23","author":"Revuz","year":"2009","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"1","key":"10.1002\/14651858.CD010081.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1365-2133.2003.05390.x","article-title":"Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa","volume":"149","author":"Sartorius","year":"2003","journal-title":"British Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD010081.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2133.2009.09198.x","article-title":"Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity","volume":"161","author":"Sartorius","year":"2009","journal-title":"British Journal of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD010081.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1365-2133.2010.09715.x","article-title":"Interobserver variability of clinical scores in hidradenitis suppurativa is low","volume":"162","author":"Sartorius","year":"2010","journal-title":"British Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD010081.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1365-2133.2011.10747.x","article-title":"Bacteriology of hidradenitis suppurativa exacerbations and deep tissue cultures obtained during carbon dioxide laser treatment","volume":"166","author":"Sartorius","year":"2012","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD010081.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5070\/D39D26366C","article-title":"A case of dissecting cellulitis and a review of the literature","volume":"9","author":"Scheinfeld","year":"2003","journal-title":"Dermatology Online Journal"},{"key":"10.1002\/14651858.CD010081.pub2-BIB0083|cit83","unstructured":"Shavit E Dreiher J Freud T Halevy S Vinker S Cohen AD Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa Journal of the European Academy of Dermatology & Venereology 10.1111\/jdv.12567"},{"issue":"1","key":"10.1002\/14651858.CD010081.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2133.2009.09430.x","article-title":"Hidradenitis suppurativa and inflammatory bowel disease: are they associated? Results of a pilot study","volume":"162","author":"Zee","year":"2010","journal-title":"British Journal of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD010081.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3109\/09546634.2012.674193","article-title":"The off-label treatment of severe hidradenitis suppurativa with TNF-\u03b1 inhibitors: a systematic review","volume":"24","author":"Rappard","year":"2013","journal-title":"Journal of Dermatological Treatment"},{"issue":"5","key":"10.1002\/14651858.CD010081.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1046\/j.1365-2133.2000.03476.x","article-title":"The clinical genetics of hidradenitis suppurativa revisited","volume":"142","author":"Werth","year":"2000","journal-title":"British Journal of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD010081.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.1468-3083.2000.00087.x","article-title":"The natural history of hidradenitis suppurativa","volume":"14","author":"Werth","year":"2000","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"2","key":"10.1002\/14651858.CD010081.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2133.2010.10034.x","article-title":"Hidradenitis suppurativa\/acne inversa: bilocated epithelial hyperplasia with very different sequelae","volume":"164","author":"Laffert","year":"2011","journal-title":"British Journal of Dermatology"},{"issue":"6007","key":"10.1002\/14651858.CD010081.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1126\/science.1196284","article-title":"Gamma-secretase gene mutations in familial acne inversa","volume":"330","author":"Wang","year":"2010","journal-title":"Science"},{"issue":"2","key":"10.1002\/14651858.CD010081.pub2-BIB0090|cit90","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003263.pub5","article-title":"Interventions for vitiligo","author":"Whitton","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD010081.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T06:01:25Z","timestamp":1683612085000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010081.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Skin Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,10,7]]},"references-count":90,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010081.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,7]]}}}